The Interpretation of Guideline for Clinical Trials Design of Gene Therapy Products for Rare Diseases(Trial Version)
In recent years, driven by policy incentives and regulatory reforms, the research and development of rare disease drugs in China has begun to show a promising future. As of March 2024, more than 30 gene therapy products for rare diseases in China have been approved for clinical trials. In order to g...
| Published in: | 罕见病研究 |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | Chinese |
| Published: |
Editorial Office of Journal of Rare Diseases
2024-07-01
|
| Subjects: | |
| Online Access: | https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2024.03.011 |